Literature DB >> 22819676

Ndrg2 regulates vertebral specification in differentiating somites.

Huang Zhu1, Jianzhi Zhao, Wenrong Zhou, Hanjun Li, Rujiang Zhou, Lingling Zhang, Haixia Zhao, Jingjing Cao, Xuming Zhu, Hongliang Hu, Gang Ma, Lin He, Zhengju Yao, Libo Yao, Xizhi Guo.   

Abstract

It is generally thought that vertebral patterning and identity are globally determined prior to somite formation. Relatively little is known about the regulators of vertebral specification after somite segmentation. Here, we demonstrated that Ndrg2, a tumor suppressor gene, was dynamically expressed in the presomitic mesoderm (PSM) and at early stage of differentiating somites. Loss of Ndrg2 in mice resulted in vertebral homeotic transformations in thoracic/lumbar and lumbar/sacral transitional regions in a dose-dependent manner. Interestingly, the inactivation of Ndrg2 in osteoblasts or chondrocytes caused defects resembling those observed in Ndrg2(-/-) mice, with a lower penetrance. In addition, forced overexpression of Ndrg2 in osteoblasts or chondrocytes also conferred vertebral defects, which were distinct from those in Ndrg2(-/-) mice. These genetic analyses revealed that Ndrg2 modulates vertebral identity in segmented somites rather than in the PSM. At the molecular level, combinatory alterations of the amount of Hoxc8-11 gene transcripts were detected in the differentiating somites of Ndrg2(-/-) embryos, which may partially account for the vertebral defects in Ndrg2 mutants. Nevertheless, Bmp/Smad signaling activity was elevated in the differentiating somites of Ndrg2(-/-) embryos. Collectively, our findings unveiled Ndrg2 as a novel regulator of vertebral specification in differentiating somites.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819676     DOI: 10.1016/j.ydbio.2012.07.001

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

1.  EZH2 regulates the balance between osteoclast and osteoblast differentiation to inhibit arthritis-induced bone destruction.

Authors:  Fang Cheng; Huimin Li; Jing Liu; Fengfeng Yan; Yu Chen; Haiyan Hu
Journal:  Genes Immun       Date:  2022-05-17       Impact factor: 2.676

2.  Postnatal lethality and abnormal development of foregut and spleen in Ndrg4 mutant mice.

Authors:  Xianghu Qu; Jing Li; H Scott Baldwin
Journal:  Biochem Biophys Res Commun       Date:  2016-01-19       Impact factor: 3.575

3.  Ndrg3 gene regulates DSB repair during meiosis through modulation the ERK signal pathway in the male germ cells.

Authors:  Hongjie Pan; Xuan Zhang; Hanwei Jiang; Xiaohua Jiang; Liu Wang; Qi Qi; Yuan Bi; Jian Wang; Qinghua Shi; Runsheng Li
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

4.  NDRG2 attenuates ischemia-induced astrocyte necroptosis via the repression of RIPK1.

Authors:  Jie Zhu; Li-Kun Yang; Qiu-Hong Wang; Wei Lin; Yi Feng; Ye-Ping Xu; Wei-Liang Chen; Kun Xiong; Yu-Hai Wang
Journal:  Mol Med Rep       Date:  2020-08-07       Impact factor: 2.952

5.  N-myc Downstream-Regulated Gene 2 (NDRG2) Promotes Bone Morphogenetic Protein 2 (BMP2)-Induced Osteoblastic Differentiation and Calcification by Janus Kinase 3 (JAK3)/Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.

Authors:  SunYu Chen; JianKun Wang; Chao Cai; Xiaoyan Xie
Journal:  Med Sci Monit       Date:  2020-01-08

6.  Genome-Wide Association Analysis Identified BMPR1A as a Novel Candidate Gene Affecting the Number of Thoracic Vertebrae in a Large White × Minzhu Intercross Pig Population.

Authors:  Qian Liu; Jingwei Yue; Naiqi Niu; Xin Liu; Hua Yan; Fuping Zhao; Xinhua Hou; Hongmei Gao; Lijun Shi; Lixian Wang; Ligang Wang; Longchao Zhang
Journal:  Animals (Basel)       Date:  2020-11-22       Impact factor: 2.752

7.  NDRG2 as a marker protein for brain astrocytes.

Authors:  Gabriele Flügge; Carolina Araya-Callis; Enrique Garea-Rodriguez; Christine Stadelmann-Nessler; Eberhard Fuchs
Journal:  Cell Tissue Res       Date:  2014-05-10       Impact factor: 5.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.